News Release
News Release
August 19,2021
August 13,2021
June 16,2021
Announcing the Start of Phase III Clinical Trials for Functional Peptide SR-0379 [PDF file]
June 1,2021
January 29,2021
Announcement of Newly Developed Antibody-inducing Peptide Compound [PDF file]
December 25,2020
Announcement of New Listing on Tokyo Stock Exchange’s Mothers [PDF file]
August 21,2020
Announcement of Fund Raising through Third Party Allocation of New Shares [PDF file]
April 8,2020
AnGes and Osaka University to Jointly Develop DNA Vaccine for COVID-19 [PDF file]
December 10,2019
Publication of Antibody-inducing Peptide Technology [PDF file]
August 21,2019